Currently out of the existing stock ratings of Sean Lee, 64 are a BUY (86.49%), 10 are a HOLD (13.51%).

Sean Lee

Work Performance Price Targets & Ratings Chart

Analyst Sean Lee, carries an average stock price target met ratio of 23.49% that have a potential upside of 39.57% achieved within 100 days. Previously, Sean Lee worked at HCWAINWRIGHT.

Sean Lee’s has documented 138 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CASI, CASI Pharmaceuticals at 03-Sep-2025.

Wall Street Analyst Sean Lee

Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 8/12/2024. The price target of $10 was fulfilled within 73 days with a profit of $7.64 (323.73%) receiving and performance score of 44.35.

Average potential price target upside

of $13.89 (194.68%) on MNPR (MONOPAR THERAPEUTICS).
of $3.6 (110.31%) on VSTM (VERASTEM).
of $2.13 (54.03%) on MYO (MYOMO).

CASI CASI Pharmaceuticals CTSO Cytosorbents Crp GRTS Gritstone Oncology ATEC Alphatec Holdings KT KT KZIA Kazia Therapeutics Ltd ADR MNPR Monopar Therapeutics PSTV Plus Therapeutics THMO Thermogenesis Holdings VIRI Virios Therapeutics Llc VSTM Verastem CRVS Corvus Pharmaceuticals MYO Myomo

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sean Lee (HC WAINWRIGHT)